Flyer

Molecular Enzymology and Drug Targets

  • ISSN: 2572-5475
  • Journal h-index: 5
  • Journal CiteScore: 0.46
  • Journal Impact Factor: 0.45
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • China National Knowledge Infrastructure (CNKI)
  • Publons
  • Google Scholar
  • Secret Search Engine Labs
  • Zenodo
Share This Page

Sumul Panday

Department of Enzymology, Abilene Christian University, United States

Publications
  • Editorial   
    Targeting the Achilles Heel: Cancer Drug Targets for Precision Therapies
    Author(s): Sumul Panday*

    Cancer remains one of the most challenging and complex diseases to combat, necessitating innovative therapeutic approaches that specifically target vulnerabilities within cancer cells. This article delves into the emerging landscape of cancer drug targets for precision therapies, focusing on the concept of targeting the "Achilles' heel" of cancer cells. Precision therapies aim to exploit unique molecular aberrations and vulnerabilities present in cancer cells, while sparing normal tissues, thereby enhancing treatment efficacy and minimizing adverse effects. The identification and validation of cancer drug targets require comprehensive genomic and proteomic analyses, uncovering key driver mutations, altered signaling pathways, and dysregulated cellular processes. Targeted therapies are designed to inhibit specific oncogenic drivers, leading.. View More»

    Abstract HTML PDF